Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

glenmark

Glenmark’s favipiravir accelerates viral clearance and clinical recovery in COVID-19 patients

July 24, 2020 Medical Communications, Research and Development COVID-19, coronavirus, favipiravir; Glenmark

The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its …
News

UCB’s investigational IL-17A and IL-17F inhibitor outclasses Novartis’ Cosentyx in plaque psoriasis

July 24, 2020 Medical Communications, Research and Development Cosentyx, UCB, pharma, psoriasis

UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ …
News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10, top 10 stories

As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for …
News
meekey

David Meeker appointed Chief Executive Officer of Rhythm Pharmaceuticals

July 23, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Rhythm Pharmaceuticals have appointed David Meeker, M.D., as its Chief Executive Officer and President of the company. Meeker succeeds interim …
Appointment
shutterstock_244903099

UK Government invests £100m in new COVID-19 vaccine manufacturing site

July 23, 2020 Manufacturing and Production, Research and Development COVID-19, UK, Vaccine, coronavirus

The UK Government’s Department for Business, Energy & Industrial Strategy has revealed a new pledge of an additional £100 million …
News
winter_mask

Research suggests COVID-19 outcomes are worse in colder months

July 23, 2020 Research and Development COVID-19, coronavirus

A partnership between Chinese and European researchers has argued that the severity of COVID-19 could be worse in colder weather …
News
800px-smallpox_vaccine

Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study

July 22, 2020 Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma

BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …
News
fda

FDA sets out guidelines on cannabis derived drugs

July 22, 2020 Research and Development CBD, CBD Oil

The FDA has released their guidelines on the rules companies should follow when developing cannabis derived drugs. The guidelines cover …
News
abbvie_0

AbbVie’s Rinvoq smashes Phase 3 efficacy targets in atopic dermatits

July 22, 2020 Research and Development AbbVie, atopic dermatits, pharma, upadacitinib

AbbVie has lifted the curtain on data from the second Phase 3 trial investigating the efficacy of Rinvoq (upadacitinib) monotherapy …
News
vaccinessssssssssssssssssss_1

US indicts two Chinese hackers for attempting to steal COVID-19 drug and vaccine research

July 22, 2020 Research and Development COVID-19 Vaccines, coronavirus, hacking, vaccines

Two Chinese hackers have been charged in the US with hacking medical companies and stealing hundreds of millions of dollars …
News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 22, 2020 Research and Development COVID-19, coronavirus

The COVID-19 news this week once again focuses on vaccines, as the UK has secured early access to 90 million …
News
shutter

Acadia’s pimavanserin falls short at Phase 3 in major depressive disorder

July 21, 2020 Manufacturing and Production, Research and Development Acadia Pharmaceuticals, major depressive disorder, phase 3, trial failure

Acadia Pharmaceuticals has lifted the lid on new Phase 3 for its therapy pimavanserin, revealing that the drug unfortunately failed …
News
512px-oxford_university_colleges-all_souls1

AstraZeneca and Oxford University’s COVID-19 vaccine generates “robust immune responses” in early interim data

July 21, 2020 Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Oxford University, Vaccine, coronavirus

Interim Phase 1/2 findings have been released for the COVID-19 highly anticipated vaccine candidate in development from Oxford University and …
News

Is Pharma doing enough on sustainability?

July 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability

Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …
Feature
shutterstock_36423250

Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show

July 20, 2020 Research and Development, Sales and Marketing COVID-19, Synairgen

Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025